PharmaCyte Biotech, Inc. (PMCB)
Nasdaq: PMCB · CIK 0001157075 · United States
Every official PharmaCyte Biotech, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open PMCB filings
PharmaCyte Biotech, Inc. documents
- PharmaCyte Biotech, Inc. 10-K 2026PMCB 10-K 2026: annual report for fiscal 2026
- PharmaCyte Biotech, Inc. 10-K 2025PMCB 10-K 2025: annual report for fiscal 2025
- PharmaCyte Biotech, Inc. 10-K 2024PMCB 10-K 2024: annual report for fiscal 2024
- PharmaCyte Biotech, Inc. 10-K 2023PMCB 10-K 2023: annual report for fiscal 2023
- PharmaCyte Biotech, Inc. 10-K 2022PMCB 10-K 2022: annual report for fiscal 2022
- PharmaCyte Biotech, Inc. 10-Q 2026PMCB 10-Q 2026: quarterly report for fiscal 2026
- PharmaCyte Biotech, Inc. 10-Q 2025PMCB 10-Q 2025: quarterly report for fiscal 2025
- PharmaCyte Biotech, Inc. 10-Q 2024PMCB 10-Q 2024: quarterly report for fiscal 2024
- PharmaCyte Biotech, Inc. 10-Q 2023PMCB 10-Q 2023: quarterly report for fiscal 2023
- PharmaCyte Biotech, Inc. 10-Q 2022PMCB 10-Q 2022: quarterly report for fiscal 2022
- PharmaCyte Biotech, Inc. 8-K 2026PMCB 8-K 2026: current report for fiscal 2026
- PharmaCyte Biotech, Inc. 8-K 2025PMCB 8-K 2025: current report for fiscal 2025
- PharmaCyte Biotech, Inc. 8-K 2024PMCB 8-K 2024: current report for fiscal 2024
- PharmaCyte Biotech, Inc. 8-K 2023PMCB 8-K 2023: current report for fiscal 2023
- PharmaCyte Biotech, Inc. 8-K 2022PMCB 8-K 2022: current report for fiscal 2022
- PharmaCyte Biotech, Inc. DEF 14A 2026PMCB DEF 14A 2026: proxy statement for fiscal 2026
- PharmaCyte Biotech, Inc. DEF 14A 2025PMCB DEF 14A 2025: proxy statement for fiscal 2025
- PharmaCyte Biotech, Inc. DEF 14A 2024PMCB DEF 14A 2024: proxy statement for fiscal 2024
- PharmaCyte Biotech, Inc. DEF 14A 2023PMCB DEF 14A 2023: proxy statement for fiscal 2023
- PharmaCyte Biotech, Inc. DEF 14A 2022PMCB DEF 14A 2022: proxy statement for fiscal 2022
- PharmaCyte Biotech, Inc. Form 4 2026PMCB Form 4 2026: insider trading filing for fiscal 2026
- PharmaCyte Biotech, Inc. Form 4 2025PMCB Form 4 2025: insider trading filing for fiscal 2025
- PharmaCyte Biotech, Inc. Form 4 2024PMCB Form 4 2024: insider trading filing for fiscal 2024
- PharmaCyte Biotech, Inc. Form 4 2023PMCB Form 4 2023: insider trading filing for fiscal 2023
- PharmaCyte Biotech, Inc. Form 4 2022PMCB Form 4 2022: insider trading filing for fiscal 2022
- PharmaCyte Biotech, Inc. S-1 2026PMCB S-1 2026: registration statement for fiscal 2026
- PharmaCyte Biotech, Inc. S-1 2025PMCB S-1 2025: registration statement for fiscal 2025
- PharmaCyte Biotech, Inc. S-1 2024PMCB S-1 2024: registration statement for fiscal 2024
- PharmaCyte Biotech, Inc. S-1 2023PMCB S-1 2023: registration statement for fiscal 2023
- PharmaCyte Biotech, Inc. S-1 2022PMCB S-1 2022: registration statement for fiscal 2022
- PharmaCyte Biotech, Inc. 13F 2026PMCB 13F 2026: institutional holdings for fiscal 2026
- PharmaCyte Biotech, Inc. 13F 2025PMCB 13F 2025: institutional holdings for fiscal 2025
- PharmaCyte Biotech, Inc. 13F 2024PMCB 13F 2024: institutional holdings for fiscal 2024
- PharmaCyte Biotech, Inc. 13F 2023PMCB 13F 2023: institutional holdings for fiscal 2023
- PharmaCyte Biotech, Inc. 13F 2022PMCB 13F 2022: institutional holdings for fiscal 2022
More companies